Delivery Order SPE2DB22D1103-SPE2DB24FTNY4
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML medical products. The contract has a ceiling value of $72,836.79 and a completion date of January 28, 2025. The contract is a delivery order with a firm fixed price pricing type. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.11, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This award is not designated under any set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award is a delivery order worth $10,114.18 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, with a performance period ending on October 11, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,271.31, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 19, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication, with a ceiling value of $5,442.75. The contract is a firm fixed-price delivery order with a completion date of June 24, 2025. The contract is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has a ceiling value of $4,336.58 and a completion date of March 5, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
The federal contract award, valued at $44,855.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the product "WEGOVY 2.4 MG/0.75 ML PEN 0.75ML" and has a Firm Fixed Price pricing type with a completion date of July 12, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a ceiling value of $18,568.83. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 26, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds...
This federal contract award, valued at $4,949.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,667.40, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of February 20, 2025. The contract is not associated with a set-aside designation, indicating open competition....